Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
Potential for drug targeting BDCA2 and TACI
CCHF in the crosshairs
Kalexo Bio formed to advance siRNA therapy for cardiovascular disorders
First liquid ambient temperature stable qPCR master mixes
Lilly to build $5bn manufacturing facility in Virginia
IND clearance for long QT syndrome treatment
Positive results from pivotal Alexander disease study
Pfizer to acquire Metsera and its obesity portfolio